New York Regulators Move To Let Medical Cannabis Patients Grow Their Own Cannabis

By Nicolas Jose Rodriguez

On Thursday, New York’s Cannabis Manage Board (CCB) voted to file a regulation that would let certified individuals to cultivate up to six cannabis plants for their have therapeutic use.

In accordance to the Cannabis Regulation & Taxation Act (MRTA) passed in 2021, home cultivation of clinical cannabis is authorized for patients 21 several years and older in the state’s Health care Hashish System.

Image by Olena Ruban/Getty Pictures

Also, selected caregivers caring for clients below 21 yrs of age (or incapable of cultivating for them selves), may possibly cultivate on behalf of the patient.

Landlords keep the option of prohibiting tenants from rising on their properties.

After a 60-working day public comment time period commencing from when the procedures are revealed, the board will critique remarks, make any essential revisions and officially file the regulations to get outcome.

Associated: Medical Flower Now Allowed In New York

In accordance to Tremaine Wright, who chairs the CCB, “The house cultivation of healthcare cannabis will offer qualified individuals with a cost-efficient suggests of getting cannabis via personalized cultivation,” described Cannabis Minute.


At the Thursday afternoon meeting, the Business office of Hashish Management furnished an update on initiatives to expunge cannabis documents.

There have been 45 expungements for conditions connected to marijuana possession so much, wrote Cannabis Minute, however most remain “under custody or supervision for additional crimes.”

A slide presentation at the conference confirmed that “Approximately 203,000 marijuana relevant prices are presently getting suppressed from qualifications lookups and in procedure to be sealed or expunged,” the slides go through. “This will incorporate to the approximately 198,000 sealing attained as component of the 1st round of marijuana expungements for the 2019 expungement laws.”

This short article at first appeared on Benzinga and has been reposted with permission.